All companies
Visit website
Animal Life Sciences
OperatingAnimal Life Sciences, Inc.
Founded 2018
Human health engineered for pets
Post-money valuation ⓘ
$6.6M
As of Oct 2020 · from Animal Life Sciences Stock 1 · pre-money + amount raised, not a traded price
Total raised
$56,454
Across 2 rounds since 2020
Latest share price
$1.00
Animal Life Sciences Stock 1 offering price
Financials
FY2018–FY2019 · from SEC filings · hover any figure for its source$0
−$2K
2018
$0
−$96K
2019
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,599
-$96,475
Taxes paid
$0
$0
Balance sheet
Cash
$16,692
$109,067
Accounts receivable
$0
$0
Total assets
$36,947
$149,568
Short-term debt
$46
$4,077
Long-term debt
$26,000
$0
Total liabilities
$26,046
$4,077
Other
Headcount
—
0
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$6.6M
post-money
Animal Life Sciences Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $56.5K / $1.1MInvestors 99Post-money $6.6M
Raised $0 / $1.1M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
99 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001797010Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.